Pharmaceutical Sales 2007

The following is a list of the top 200 pharmaceutical drugs by retail sales in 2007, listed by U.S. sales value and brand name.
New: Quarterly Top 100 prescription sales data now available, from Q1 2011 more....

Top 200 Drugs for 2007 by Sales

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Rank Drug Current Manufacturer Total Sales ($000) % Change 2006
1 Lipitor Pfizer Inc 6,165,531 -6.3%
2 Nexium AstraZeneca Pharmaceuticals 4,355,901 7.3%
3 (1) Advair Diskus GlaxoSmithKline 3,390,766 8.8%
4 (1) Prevacid Takeda Pharmaceuticals North America, Inc 3,315,740 0.3%
5 (2) Plavix Bristol-Myers Squibb Company 3,082,712 38.1%
6 (1) Singulair Merck & Co., Inc. 2,863,326 16.4%
7 (4) Seroquel AstraZeneca Pharmaceuticals 2,518,409 21.4%
8 (2) Effexor XR Pfizer Inc 2,464,396 9.7%
9 (1) Lexapro Forest Pharmaceuticals, Inc 2,304,364 9.8%
10 (4) Actos Takeda Pharmaceuticals North America, Inc 2,229,333 15.7%
11 (1) Protonix Wyeth 2,136,899 5.7%
12 (10) Vytorin Merck & Co., Inc. 1,938,882 32.0%
13 (7) Topamax Janssen Pharmaceuticals, Inc 1,837,388 20.8%
14 (4) Risperdal Janssen Pharmaceuticals, Inc 1,790,436 8.1%
15 (9) Abilify Bristol-Myers Squibb Company 1,781,562 25.7%
16 (19) Cymbalta Eli Lilly and Company 1,732,827 59.8%
17 (9) Lamictal GlaxoSmithKline 1,717,429 29.4%
18 (1) Zyprexa Eli Lilly and Company 1,579,252 2.8%
19 (6) Levaquin Janssen Pharmaceuticals, Inc 1,433,000 1.7%
20 (7) Celebrex Pfizer Inc 1,416,084 7.6%
21 (11) Zetia Merck & Co., Inc. 1,405,066 23.3%
22 (9) Valtrex GlaxoSmithKline 1,395,313 21.3%
23 (14) Crestor AstraZeneca Pharmaceuticals 1,367,276 29.2%
24 (1) Fosamax Merck & Co., Inc. 1,355,725 -5.0%
25 (4) Zyrtec Johnson & Johnson 1,302,807 12.0%
26 (12) Lantus Sanofi (formerly Sanofi Aventis) 1,302,555 23.1%
27 (6) Adderall XR Shire US Inc 1,288,884 13.9%
28 (11) Diovan Novartis Corporation 1,117,415 15.0%
29 (12) Avandia GlaxoSmithKline 1,110,458 -33.3%
30 (10) Tricor Abbott Laboratories 1,106,518 14.6%
31 (3) Aciphex Eisai Corporation 1,099,427 -1.2%
32 (10) Diovan HCT Novartis Corporation 1,051,823 21.4%
33 (18) OxyContin Purdue Pharma LP 1,043,703 52.8%
34 (7) Concerta Johnson & Johnson 1,030,703 10.1%
35 (5) Coreg GlaxoSmithKline 1,013,939 -12.5%
36 (11) Flomax Boehringer Ingelheim Pharmaceuticals, Inc 1,002,163 27.6%
37 (15) Lyrica Pfizer Inc 1,000,069 53.6%
38 (22) Wellbutrin XL Valeant Pharmaceuticals International 992,372 -40.6%
39 (5) Aricept Eisai Corporation 983,397 22.9%
40 (3) Imitrex Oral GlaxoSmithKline 950,585 10.8%
41 (28) Ambien Pfizer Inc 920,070 -52.5%
42 (14) Lotrel Novartis Corporation 908,174 -29.8%
43 (2) Nasonex Merck & Co., Inc. 892,534 13.1%
44 (23) Toprol XL AstraZeneca Pharmaceuticals 888,208 -39.7%
45 (22) Ambien CR Sanofi (formerly Sanofi Aventis) 876,028 58.4%
46 (10) Enbrel Amgen Inc. 874,840 -19.3%
47 (12) Spiriva Boehringer Ingelheim Pharmaceuticals, Inc 868,226 46.3%
48 (2) Viagra Pfizer Inc 824,946 4.9%
49 (6) Lidoderm Endo Pharmaceuticals 808,118 27.1%
50 (2) Actonel Procter & Gamble 791,023 1.3%
51 () Chantix Pfizer Inc 764,723 777.5%
52 (43) Norvasc Pfizer Inc 749,521 -65.1%
53 (5) Lovenox Sanofi (formerly Sanofi Aventis) 746,154 25.1%
54 Provigil Cephalon, Inc. 744,625 15.5%
55 (6) Lunesta Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) 712,740 22.1%
56 (6) Altace King Pharmaceuticals, Inc. (now part of Pfizer - October 2010) 710,056 -1.0%
57 (24) Keppra UCB Inc. 708,462 42.0%
58 (14) Geodon Oral Pfizer Inc 665,033 25.6%
59 (3) Cozaar Merck & Co., Inc. 652,032 5.4%
60 Detrol LA Pfizer Inc 635,709 8.8%
61 () Atripla Gilead Sciences, Inc. 617,195 471.0%
62 (4) Truvada Gilead Sciences, Inc. 606,223 6.4%
63 (15) CellCept Roche Pharmaceuticals 599,290 18.1%
64 (9) Pulmicort Respules AstraZeneca Pharmaceuticals 592,447 13.8%
65 (6) Humalog Eli Lilly and Company 592,322 11.0%
66 (14) Depakote ER Abbott Laboratories 577,034 15.0%
67 (2) Depakote Abbott Laboratories 573,990 5.9%
68 (4) Premarin Tabs Wyeth 557,390 -3.3%
69 (7) Synthroid Abbott Laboratories 547,587 -5.5%
70 (15) Niaspan Abbott Laboratories 546,407 15.3%
71 (26) Byetta Amylin Pharmaceuticals, Inc. 541,012 49.0%
72 () Budeprion XL Teva Pharmaceuticals 537,370 >999
73 (10) Strattera Eli Lilly and Company 535,516 -7.3%
74 (4) Combivent Boehringer Ingelheim Pharmaceuticals, Inc 534,045 -0.1%
75 (1) Trileptal Novartis Corporation 532,376 3.7%
76 Yasmin 28 Bayer Healthcare Pharmaceuticals 528,314 4.0%
77 (6) Flovent HFA GlaxoSmithKline 521,165 9.3%
78 (4) Skelaxin Elan Corporation 517,367 7.1%
79 (7) Prograf Astellas Pharma US 515,999 15.7%
80 (7) Arimidex AstraZeneca Pharmaceuticals 506,414 13.5%
81 (4) Evista Eli Lilly and Company 503,390 -0.9%
82 (2) Hyzaar Merck & Co., Inc. 499,947 5.3%
83 (9) Namenda Forest Pharmaceuticals, Inc 489,713 26.6%
84 () Januvia Merck & Co., Inc. 471,698 >999
85 (6) Humira Abbott Laboratories 462,619 -8.5%
86 (7) Cialis Eli Lilly and Company 453,233 20.8%
87 (7) Reyataz Bristol-Myers Squibb Company 438,766 17.7%
88 (2) Xalatan Pfizer Inc 430,887 6.7%
89 (40) Omnicef Abbott Laboratories 429,207 -44.5%
90 (12) Avelox Bayer Healthcare Pharmaceuticals 424,410 26.5%
91 () ProAir HFA Teva Pharmaceuticals 421,205 678.6%
92 (1) Asacol Procter & Gamble 420,880 8.4%
93 (11) Benicar HCT Daiichi Sankyo 414,253 24.1%
94 () Fentanyl Oral Citrate 408,202 515.9%
95 (27) Requip GlaxoSmithKline 407,665 56.3%
96 (23) Boniva Genentech, Inc (member of Roche group) 404,109 49.5%
97 (24) Caduet Pfizer Inc 388,401 0.2%
98 (2) Avapro Bristol-Myers Squibb Company 384,664 0.2%
99 (2) Gleevec Novartis Corporation 384,572 13.7%
100 Kaletra Abbott Laboratories 373,247 6.0%
101 (6) Ortho Tri-Cyclen Lo Ortho-McNeil-Janssen Pharmaceuticals, Inc. 371,544 -0.1%
102 (6) Benicar Daiichi Sankyo 369,641 18.2%
103 (10) AndroGel Abbott Laboratories 366,053 23.8%
104 (3) Xopenex Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) 354,528 10.8%
105 (17) Procrit Centocor Ortho Biotech, Inc 353,189 -15.6%
106 (49) Lamisil Oral Novartis Corporation 339,700 -44.6%
107 (4) Avalide Bristol-Myers Squibb Company 328,733 9.3%
108 (4) Nasacort AQ Sanofi (formerly Sanofi Aventis) 318,329 6.3%
109 (10) Combivir GlaxoSmithKline 318,175 -10.6%
110 (7) Allegra-D 12 Hour Sanofi (formerly Sanofi Aventis) 316,629 -5.5%
111 (13) Duragesic Johnson & Johnson 306,188 -14.3%
112 (3) Copaxone Sanofi (formerly Sanofi Aventis) 303,546 -0.7%
113 (20) RenaGel Genzyme Corporation 293,520 29.8%
114 (16) Femara Novartis Corporation 293,473 23.6%
115 () Enbrel Sureclick Amgen Inc. 293,334 539.1%
116 (13) NovoLog Mix 70/30 Novo Nordisk Inc. 292,372 22.8%
117 (11) Clarinex Merck & Co., Inc. 288,965 -8.6%
118 (10) Aldara Medicis Pharmaceutical Corporation 287,596 18.4%
119 (5) Forteo Eli Lilly and Company 282,368 -4.3%
120 (78) Suboxone Reckitt Benckiser Pharmaceuticals Inc. 282,277 105.9%
121 (25) Avodart GlaxoSmithKline 281,353 45.9%
122 (17) Paxil CR Apotex Corp 280,659 -14.2%
123 (2) Norvir Abbott Laboratories 275,199 10.3%
124 (75) Avandamet GlaxoSmithKline 275,098 101.6%
125 (13) Restasis Allergan, Inc 274,733 31.7%
126 (10) Avonex Biogen Idec 266,929 -7.7%
127 (28) Sensipar Amgen Inc. 266,344 49.8%
128 (2) Tarceva Genentech, Inc (member of Roche group) 263,888 7.5%
129 (14) Patanol Alcon Laboratories, Inc. 258,569 -11.1%
130 () Yaz Bayer Healthcare Pharmaceuticals 254,592 584.0%
131 () Lovaza GlaxoSmithKline 252,684 121.5%
132 (13) Mirapex Boehringer Ingelheim Pharmaceuticals, Inc 249,807 26.5%
133 (43) Focalin XR Novartis Corporation 249,083 56.6%
134 Cosopt Merck & Co., Inc. 242,791 8.5%
135 (4) Zyvox Pfizer Inc 236,407 15.5%
136 (14) Epzicom GlaxoSmithKline 230,664 27.2%
137 (24) NuvaRing Merck & Co., Inc. 230,608 33.2%
138 (70) Actiq Abbott Laboratories 230,068 -57.9%
139 (61) Fosamax Plus D Merck & Co., Inc. 229,969 69.1%
140 () Actoplus Met Takeda Pharmaceuticals North America, Inc 229,800 94.9%
141 Lumigan Allergan, Inc 226,765 11.4%
142 (18) Rhinocort Aqua AstraZeneca Pharmaceuticals 225,667 -11.4%
143 () Solodyn Medicis Pharmaceutical Corporation 224,549 247.7%
144 (26) Thalomid Celgene Corporation 222,918 -18.6%
145 (22) Fuzeon Roche Pharmaceuticals 220,522 -13.9%
146 (2) Astelin Meda Pharmaceuticals 219,377 17.3%
147 (5) BenzaClin Sanofi (formerly Sanofi Aventis) 213,158 5.0%
148 (8) Relpax Pfizer Inc 212,412 3.9%
149 (14) Viread Gilead Sciences, Inc. 210,770 -5.8%
150 (3) Casodex AstraZeneca Pharmaceuticals 207,469 7.7%
151 (2) Vigamox Alcon Laboratories, Inc. 207,107 12.2%
152 () Vesicare Astellas Pharma US 205,637 77.6%
153 (10) Humalog Mix 75/25 Pn 204,322 2.0%
154 (18) Trizivir GlaxoSmithKline 203,230 -8.7%
155 (18) Budeprion SR Teva Pharmaceuticals 201,458 -4.6%
156 (4) Xeloda Genentech, Inc (member of Roche group) 201,453 12.2%
157 (47) Sustiva Bristol-Myers Squibb Company 200,006 -33.5%
158 (2) Levitra Bayer Healthcare Pharmaceuticals 197,578 11.4%
159 (27) Endocet Endo Pharmaceuticals 193,882 -14.5%
160 (32) Risperdal Consta Janssen Pharmaceuticals, Inc 193,837 36.1%
161 (24) Aggrenox Boehringer Ingelheim Pharmaceuticals, Inc 193,202 27.1%
162 () Humira Pen Abbott Laboratories 191,244 741.1%
163 (20) Kadian Actavis 191,097 23.6%
164 (1) Differin Galderma Laboratories 188,171 11.4%
165 (5) Catapres-TTS Boehringer Ingelheim Pharmaceuticals, Inc 187,374 7.6%
166 (2) Alphagan P Allergan, Inc 186,087 9.7%
167 (14) Tussionex Sanofi (formerly Sanofi Aventis) 179,288 -0.1%
168 (5) Zyrtec Syrup 177,659 3.7%
169 (21) Maxalt Merck & Co., Inc. 176,736 22.4%
170 (155) Zoloft Pfizer Inc 175,209 -90.1%
171 (12) Prilosec AstraZeneca Pharmaceuticals 174,360 -0.2%
172 (7) Ciprodex Otic Alcon Laboratories, Inc. 174,205 10.6%
173 (16) Temodar Merck & Co., Inc. 173,446 -2.1%
174 (7) Tobradex Alcon Laboratories, Inc. 172,827 3.7%
175 (9) Zyrtec-D Pfizer Inc 163,579 -2.6%
176 () Welchol Daiichi Sankyo 161,769 23.8%
177 (18) Maxalt MLT 161,644 15.5%
178 () Asmanex Merck & Co., Inc. 161,181 75.0%
179 (2) Atacand AstraZeneca Pharmaceuticals 160,656 2.6%
180 (26) Coumadin Tabs Bristol-Myers Squibb Company 160,548 -10.2%
181 (10) Dovonex Bristol-Myers Squibb Company 159,439 11.1%
182 (13) Klor-Con Upsher-Smith Laboratories Inc. 159,314 -2.4%
183 (1) Pegasys Genentech, Inc (member of Roche group) 156,056 0.7%
184 () Ultram ER Ortho-McNeil-Janssen Pharmaceuticals, Inc. 155,482 117.0%
185 (7) Betaseron Bayer Healthcare Pharmaceuticals 151,954 -3.8%
186 () Zovirax Topical GlaxoSmithKline 151,892 18.8%
187 (7) Trinessa Watson Pharmaceuticals, Inc. (now Actavis, Inc) 151,782 -3.6%
188 Pulmozyme Genentech, Inc (member of Roche group) 150,833 3.7%
189 (15) Neupogen Amgen Inc. 150,110 -5.8%
190 (20) Humulin N Eli Lilly and Company 149,884 -8.2%
191 () Micardis HCT Abbott Laboratories 148,149 34.0%
192 (61) Ortho Evra Ortho-McNeil-Janssen Pharmaceuticals, Inc. 148,137 -36.4%
193 () Allegra-D 24 Hour Sanofi (formerly Sanofi Aventis) 148,044 34.2%
194 () Fentora Cephalon, Inc. 147,533 762.8%
195 () Enablex Warner Chilcott 147,373 61.5%
196 (24) Famvir GlaxoSmithKline 146,793 -8.6%
197 (10) Avinza King Pharmaceuticals, Inc. (now part of Pfizer - October 2010) 145,694 -2.5%
198 (2) Prempro Pfizer Inc 144,877 4.4%
199 () Coreg CR GlaxoSmithKline 144,854 NA
200 () Marinol Roxane Laboratories,Inc. 144,668 14.3%
All Others 25,961,547 -11.7%

Source: Verispan, VONA

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Hide
(web5)